Recall of Argyle Single Lumen Polyurethane Umbilical Vessel Catheter (Intended for short-term vascular access via umbilical vessels in neonatal patients)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Covidien Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
    Class II
  • Event Initiated Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    The instructions for use was updated to address the increasing use of disinfectants containing alcohol and/or acetone to clean vascular access devices. the use of these disinfectants can cause damage to the polyurethane contained in the catheter and make it more susceptible to physical damage, which may ultimately lead to the need to replace the catheter.
  • Action
    Covidien has updated the instructions for use for polyurethane single lumen umbilical vessel catheters to include additional information on the care of the device.


  • Model / Serial
    Argyle Single Lumen Polyurethane Umbilical Vessel Catheter (Intended for short-term vascular access via umbilical vessels in neonatal patients)Product IDs: 8888160325, 8888160333, 8888160341ARTG Number: 149128
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source